← Leaderboards
William Carroll
University Of Alabama At Birmingham
$308,706
Attributed
$617,412
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $268.1K · FY2015–20$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$617,412 · 2
By mechanism
R21$617,412 · 2
Top collaborators
- Isabel C Scarinci3 shared
- Jason Morgan Warram1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Mona N. Fouad$53,629,242
- Eben L Rosenthal$10,844,750
- Martha R Crowther$591,564
- Barry P Sleckman$19,849,738
- Isabel C Scarinci$19,061,797
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsHead And Neck CancerCounselingCommunitiesAdoptionControl GroupsAbstinenceCare SeekingCombination Drug TherapyBehavioral Risk Factor Surveillance SystemAge-YearsCancer CenterAlabamaComparison GroupCarbon MonoxideAdvisory CommitteesCessation Of LifeBaseAfrican AmericanCigaretteCigarette SmokeCigarette SmokerCigarette SmokingCognitive Therapy
Grant awards (4)
Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability$77,009
R21 · FY2020 · CA
Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability$110,773
R21 · FY2019 · CA
Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability$161,494
R21 · FY2018 · CA
Imaging Guided Surgery using Fluorescently Labeled Cetuximab$268,136
R21 · FY2015 · CA